Oxidative stress in diabetes

被引:173
作者
Piconi, L
Quagliaro, L
Ceriello, A
机构
[1] Univ Udine, Chair Internal Med, I-33100 Udine, Italy
[2] Univ Udine, Dept Pathol & Med Expt & Clin, I-33100 Udine, Italy
[3] Morpurgo Hofman Res Lab Aging, Udine, Italy
关键词
oxidative stress markers; diabetes; 8-hydroxy-2 '-dexoyguanosine; malondialdehyde; nitrotyrosine;
D O I
10.1515/CCLM.2003.177
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Increasing evidence in both experimental and clinical studies suggests that there is a close link between hyperglycemia, oxidative stress and diabetic complications. High blood glucose level determines overproduction of reactive oxygen species (ROS) by the mitochondria electron transport chain. High reactivity of ROS determines chemical changes in virtually all cellular components, leading to DNA and protein modification and lipid peroxidation. Measurement of biomarkers such 8-hydroxy-2deoxyguanosine (8-OHdG), isoprostanes, malondialdehyde (MDA) and nitrotyrosine is a useful tool to assess the oxidative stress of the organism. Knowledge of the mechanisms of ROS damage of is the first step for development of new therapeutic molecules and for rationalizing the use of existing drugs.
引用
收藏
页码:1144 / 1149
页数:6
相关论文
共 66 条
[11]   Role of hyperglycemia in nitrotyrosine postprandial generation [J].
Ceriello, A ;
Quagliaro, L ;
Catone, B ;
Pascon, R ;
Piazzola, M ;
Bais, B ;
Marra, G ;
Tonutti, L ;
Taboga, C ;
Motz, E .
DIABETES CARE, 2002, 25 (08) :1439-1443
[12]   Total radical-trapping antioxidant parameter in NIDDM patients [J].
Ceriello, A ;
Bortolotti, N ;
Falleti, E ;
Taboga, C ;
Tonutti, L ;
Crescentini, A ;
Motz, E ;
Lizzio, S ;
Russo, A ;
Bartoli, E .
DIABETES CARE, 1997, 20 (02) :194-197
[13]  
Ceriello A, 2002, DIABETES NUTR METAB, V15, P121
[14]  
Ceriello A, 2002, INT J CLIN PRACT, P51
[15]   Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation - Effects of short- and long-term simvastatin treatment [J].
Ceriello, A ;
Taboga, C ;
Tonutti, L ;
Quagliaro, L ;
Piconi, L ;
Bais, B ;
Da Ros, R ;
Motz, E .
CIRCULATION, 2002, 106 (10) :1211-1218
[16]   Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients [J].
Ceriello, A ;
Bortolotti, N ;
Pirisi, M ;
Crescentini, A ;
Tonutti, L ;
Motz, E ;
Russo, A ;
Giacomello, R ;
Stel, G ;
Taboga, C .
DIABETES CARE, 1997, 20 (10) :1589-1593
[17]   Measurement of DNA oxidation in human cells by chromatographic and enzymic methods [J].
Collins, A ;
Gedik, C ;
Vaughan, N ;
Wood, S ;
White, A ;
Dubois, J ;
Rees, JF ;
Loft, S ;
Moller, P ;
Cadet, J ;
Douki, T ;
Ravanat, JL ;
Sauvaigo, S ;
Faure, H ;
Morel, I ;
Morin, M ;
Epe, B ;
Phoa, N ;
Hartwig, A ;
Schwerdtle, T ;
Dolara, P ;
Giovannelli, L ;
Lodovici, M ;
Olinski, R ;
Bialkowski, K ;
Foksinski, M ;
Gackowski, D ;
Duracková, Z ;
Hlinciková, L ;
Korytar, P ;
Sivonová, M ;
Dusinská, M ;
Mislanová, C ;
Viña, J ;
Möller, L ;
Hofer, T ;
Nygren, J ;
Gremaud, E ;
Herbert, K ;
Lunec, J ;
Wild, C ;
Hardie, L ;
Olliver, J ;
Smith, E .
FREE RADICAL BIOLOGY AND MEDICINE, 2003, 34 (08) :1089-1099
[18]   DNA damage in diabetes:: Correlation with a clinical marker [J].
Collins, AR ;
Raslová, K ;
Somorovská, M ;
Petrovská, H ;
Ondrusová, A ;
Vohnout, B ;
Fábry, R ;
Dusinská, M .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (03) :373-377
[19]   Effects of the protein kinase Cβ inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes [J].
Cotter, MA ;
Jack, AM ;
Cameron, NE .
CLINICAL SCIENCE, 2002, 103 (03) :311-321
[20]  
Cuzzocrea S, 2001, PHARMACOL REV, V53, P135